Titre A Comprehensive and Observational Myeloproliferative Neoplasms Registry in the Province of Quebec (MPN Registry)
Protocole ID Registre des NMP (CINC424BCA04T)
ClinicalTrials.gov ID
Type(s) de cancer NMP : Vaquez , Thrombocythémie essentielle, Métaplasie myéloide
Phase Autres
Institution CISSS DE LAVAL
   HOPITAL DE LA CITE-DE-LA-SANTE
      1755 boul. René-Laennec, Laval, QC, H7M 3L9
Ville Laval
Investigateur(trice) principal(e) Dre Danielle Talbot
Coordonnateur(trice) Solange Tremblay
450-668-1010 poste 23603
Statut Actif en recrutement
Critètes d'éligibilité
All patients who meet the following inclusion criteria may be enrolled in the MPN Registry:
  • Have a diagnosis of PV, ET, or MF as defined by the World Health Organization (WHO) diagnostic criteria for myeloproliferative neoplasms [7];
  • Are 18 years of age or older;
  • Are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable.
Critètes d'exclusion Patients who meet any of the following criteria will be excluded from participation:
  • Life expectancy of less than 3 months for a condition not related to MPN;
  • Patients suffering of CML.